Drug Approval | July 26, 2022
Lupin receives approval from U.S. FDA for Azilsartan Medoxomil Tablets
The product will be manufactured at Lupin's facility in Nagpur, India.
The product will be manufactured at Lupin's facility in Nagpur, India.
Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
Expanding diagnostics footprint in East India
Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy to adulthood
Based on a post hoc analysis, fewer required respiratory interventions
Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
Dupixent is the first and only medicine indicated to treat eosinophilic esophagitis in the United States; approval granted more than two months ahead of USFDA’s Priority Review action date
Subscribe To Our Newsletter & Stay Updated
